Cresco Labs is trading 6.1% up at $0.78, with no clear catalyst identified.

  • No new company-specific announcement dated August 31, 2026, has been identified.
  • The broader U.S. market is modestly lower, so the gain is not clearly explained by a major market-wide move.
  • The latest significant company news remains the August 6 second-quarter report, which showed $173 million in revenue and $40 million in adjusted EBITDA, but it is not fresh enough to establish causation.